Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVPFree Report) in a research report report published on Saturday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Price Performance

RVP stock opened at $1.19 on Friday. The firm has a 50 day moving average of $1.08 and a 200-day moving average of $1.14. The company has a current ratio of 11.02, a quick ratio of 8.18 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $35.63 million, a P/E ratio of -4.58 and a beta of 2.08. Retractable Technologies has a 12 month low of $0.87 and a 12 month high of $1.34.

Retractable Technologies (NYSE:RVPGet Free Report) last released its quarterly earnings results on Wednesday, May 15th. The company reported $0.01 EPS for the quarter. The firm had revenue of $7.60 million during the quarter. Retractable Technologies had a negative net margin of 18.84% and a negative return on equity of 7.55%.

Insiders Place Their Bets

In related news, CEO Thomas J. Shaw bought 48,635 shares of the stock in a transaction that occurred on Thursday, May 16th. The shares were acquired at an average cost of $1.03 per share, with a total value of $50,094.05. Following the completion of the purchase, the chief executive officer now directly owns 14,417,148 shares of the company’s stock, valued at approximately $14,849,662.44. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders have acquired 146,643 shares of company stock worth $150,177 in the last ninety days. 54.60% of the stock is currently owned by insiders.

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Featured Articles

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.